- Home
- GPCR vs STR Comparison
GPCR vs STR Comparison
Compare GPCR & STR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- STR
- Stock Information
- Founded
- GPCR 2016
- STR 2016
- Country
- GPCR United States
- STR United States
- Employees
- GPCR N/A
- STR N/A
- Industry
- GPCR
- STR Oil & Gas Production
- Sector
- GPCR
- STR Energy
- Exchange
- GPCR Nasdaq
- STR Nasdaq
- Market Cap
- GPCR 1.6B
- STR 1.6B
- IPO Year
- GPCR 2023
- STR N/A
- Fundamental
- Price
- GPCR $23.77
- STR $20.02
- Analyst Decision
- GPCR Strong Buy
- STR Buy
- Analyst Count
- GPCR 7
- STR 5
- Target Price
- GPCR $81.29
- STR $29.25
- AVG Volume (30 Days)
- GPCR 752.3K
- STR 539.7K
- Earning Date
- GPCR 03-07-2025
- STR 02-26-2025
- Dividend Yield
- GPCR N/A
- STR 7.50%
- EPS Growth
- GPCR N/A
- STR N/A
- EPS
- GPCR N/A
- STR N/A
- Revenue
- GPCR N/A
- STR $618,668,000.00
- Revenue This Year
- GPCR N/A
- STR $5.84
- Revenue Next Year
- GPCR N/A
- STR N/A
- P/E Ratio
- GPCR N/A
- STR N/A
- Revenue Growth
- GPCR N/A
- STR 13.74
- 52 Week Low
- GPCR $22.33
- STR $18.40
- 52 Week High
- GPCR $62.74
- STR $25.95
- Technical
- Relative Strength Index (RSI)
- GPCR 37.89
- STR 45.01
- Support Level
- GPCR $22.33
- STR $19.55
- Resistance Level
- GPCR $25.17
- STR $20.21
- Average True Range (ATR)
- GPCR 1.73
- STR 0.47
- MACD
- GPCR -0.37
- STR 0.00
- Stochastic Oscillator
- GPCR 15.94
- STR 46.67
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
About STR Sitio Royalties Corp.
Sitio Royalties Corp is a pure-play mineral and royalty company. The group focuses on investing in mineral and royalty interests in the Permian and other productive U.S. oil basins.